Early disease, early detection, early treatment: Some common threads and some important problems

Pre-Invasive Disease: Pathogenesis and Clinical Management

Volumn , Issue , 2011, Pages 495-507

  Potter, John D ^a  

^a USA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84900126805     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-4419-6694-0_23     Document Type: Chapter

References (47)

1. Etzioni R, Penson DF, Legler JM, di Tommaso D, Boer R et al (2002) Overdiagnosis due to prostate-specific antigen screening: lessons from U.S. prostate cancer incidence trends. J Natl Cancer Inst 94(13):981-990
2. Zahl PH, Strand BH, Maehlen J (2004) Incidence of breast cancer in Norway and Sweden during introduction of nationwide screening: prospective cohort study. BMJ 328(7445): 921-924
3. Pepe MS, Etzioni R, Feng Z, Potter JD, Thornquist MD et al (2001) Phases of biomarker development for early detection of cancer. J Natl Cancer Inst 93:1054-1061
4. Subramanian S, Bobashev G, Morris RJ (2009) Modeling the cost-effectiveness of colorectal cancer screening: policy guidance based on patient preferences and compliance. Cancer Epidemiology Biomarkers Prev 18(7):1971-1978
5. Bissell MJ, Labarge MA (2005) Context, tissue plasticity, and cancer: are tumor stem cells also regulated by the microenvironment? Cancer Cell 7(1):17-23
6. Potter JD (2007) Morphogens, morphostats, microarchitecture and malignancy. Nat Rev Cancer 7(6):464-474
7. Palmer C, Duan X, Hawley S, Scholler N, Thorpe JD et al (2008) Systematic evaluation of candidate blood markers for detecting ovarian cancer. PLoS One 3(7):e2633
8. Henschke CI, Yankelevitz DF, Libby DM, Pasmantier MW, Smith JP et al (2006) Survival of patients with stage I lung cancer detected on CT screening. N Engl J Med 355(17):1763-1771
9. Hingorani SR, Petricoin EF, Maitra A, Rajapakse V, King C et al (2003) Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse. Cancer Cell 4(6):437-450
10. Hingorani SR, Wang L, Multani AS, Combs C, Deramaudt TB et al (2005) Trp53R172H and KrasG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice. Cancer Cell 7(5):469-483
11. Izeradjene K, Combs C, Best M, Gopinathan A, Wagner A et al (2007) Kras(G12D) and Smad4/Dpc4 haploinsufficiency cooperate to induce mucinous cystic neoplasms and invasive adenocarcinoma of the pancreas. Cancer Cell 11(3):229-243
12. Bach PB (2008) Is our natural-history model of lung cancer wrong? Lancet Oncol 9(7):693-697
13. Petricoin EF, Ardekani AM, Hitt BA, Levine PJ, Fusaro VA et al (2002) Use of proteomic patterns in serum to identify ovarian cancer. Lancet 359(9306):572-577
14. Potter JD (2001) At the interfaces of epidemiology, genetics, and genomics. Nat Rev Genet 2:142-147
15. Bissell MJ, Radisky D (2001) Putting tumours in context. Nat Rev Cancer 1:46-54
16. Vachon CM, Sellers TA, Carlson EE, Cunningham JM, Hilker CA et al (2007) Strong evidence of a genetic determinant for mammographic density, a major risk factor for breast cancer. Cancer Res 67(17):8412-8418
17. Potter J (2009) Chemoprevention: why do we keep getting it wrong? Presentation for 2009 AACR-American Cancer Society Award for Research Excellence in Cancer Epidemiology and Prevention, 100th AACR Meeting, Denver CO
18. Cancer Prevention Study Group ATBC (1994) The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. N Engl J Med 330:1029-1035
19. Omenn G, Goodman G, Thornquist M, Balmes J, Cullen M et al (1996) Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. N Engl J Med 334:1150-1155
20. Potter JD (1996) Chemoprevention: pharmacology or biology? Oncology 10:1487-1488
21. Neuhouser ML, Patterson RE, Thornquist MD, Omenn GS, King IB et al (2003) Fruits and vegetables are associated with lower lung cancer risk only in the placebo arm of the beta-carotene and retinol efficacy trial (CARET). Cancer Epidemiol Biomarkers Prev 12(4):350-358
22. Baron JA, Cole BF, Sandler RS, Haile RW, Ahnen D et al (2003) A randomized trial of aspirin to prevent colorectal adenomas. N Engl J Med 348(10):891-899
23. Sandler RS, Halabi S, Baron JA, Budinger S, Paskett E et al (2003) A randomized trial of aspirin to prevent colorectal adenomas in patients with previous colorectal cancer. N Engl J Med 348(10):883-890
24. Flossmann E, Rothwell PM (2007) Effect of aspirin on long-term risk of colorectal cancer: consistent evidence from randomised and observational studies. Lancet 369(9573):1603-1613
25. Cook NR, Lee IM, Gaziano JM, Gordon D, Ridker PM et al (2005) Low-dose aspirin in the primary prevention of cancer: the Women's Health Study: A randomized controlled trial. JAMA 294(1):47-55
26. Arber N, Eagle CJ, Spicak J, Racz I, Dite P et al (2006) Celecoxib for the prevention of colorectal adenomatous polyps. N Engl J Med 355(9):885-895
27. Bertagnolli MM, Eagle CJ, Zauber AG, Redston M, Solomon SD et al (2006) Celecoxib for the prevention of sporadic colorectal adenomas. N Engl J Med 355(9):873-884
28. Psaty BM, Potter JD (2006) Risks and benefits of celecoxib to prevent recurrent adenomas. New Engl J Med 355(9):950-952
29. Cole BF, Baron JA, Sandler RS, Haile RW, Ahnen DJ et al (2007) Folic acid for the prevention of colorectal adenomas: A randomized clinical trial. JAMA 297(21):2351-2359
30. Ulrich CM, Potter JD (2007) Folate and cancer-timing is everything. JAMA 297(21):2408-2409
31. Figueiredo JC, Grau MV, Haile RW, Sandler RS, Summers RW et al (2009) Folic acid and risk of prostate cancer: results from a randomized clinical trial. J Natl Cancer Inst 101(6):432-435
32. Qiao Y-L, Dawsey SM, Kamangar F, Fan J-H, Abnet CC et al (2009) Total and cancer mortality after supplementation with vitamins and minerals: follow-up of the Linxian general population nutrition intervention trial. J Natl Cancer Inst 101(7):507-518
33. Baron JA, Beach M, Mandel JS, van Stolk RU, Haile RW et al (1999) Calcium supplements for the prevention of colorectal adenomas. N Engl J Med 340:101-107
34. Grau MV, Baron JA, Sandler RS, Haile RW, Beach ML et al (2003) Vitamin D, calcium supplementation, and colorectal adenomas: results of a randomized trial. J Natl Cancer Inst 95(23):1765-1771
35. Kristal AR, Cohen JH, Qu P, Stanford JL (2002) Associations of energy, fat, calcium, and vitamin D with prostate cancer risk. Cancer Epidemiology Biomarkers Prev 11(8):719-725
36. McMichael AJ, Potter JD (1980) Reproduction, endogenous and exogenous sex hormones, and colon cancer: A review and hypothesis. J Natl Cancer Inst 65(6):1201-1207
37. Potter J, McMichael A (1983) Large bowel cancer in women in relation to reproductive and hormonal factors: A case-control study. J Natl Cancer Inst 4:703-709
38. Potter JD, Bostick RM, Grandits GA, Fosdick L, Elmer P et al (1996) Hormone replacement therapy is associated with lower risk of adenomatous polyps of the large bowel: the Minnesota Cancer Prevention Research Unit Case-Control Study. Cancer Epidemiol Biomarkers Prev 5(10):779-784
39. Chlebowski RT, Wactawski-Wende J, Ritenbaugh C, Hubbell FA, Ascensao J et al (2004) Estrogen plus progestin and colorectal cancer in postmenopausal women. N Engl J Med 350(10):991-1004
40. Chlebowski RT, Hendrix SL, Langer RD, Stefanick ML, Gass M et al (2003) Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women's Health Initiative Randomized Trial. JAMA 289(24):3243-3253
41. Manson JE, Hsia J, Johnson KC, Rossouw JE, Assaf AR et al (2003) Estrogen plus progestin and the risk of coronary heart disease. N Engl J Med 349(6):523-534
42. Shu XO, Jin F, Dai Q, Wen W, Potter JD et al (2001) Soyfood Intake during adolescence and subsequent risk of breast cancer among Chinese women. Cancer Epidemiology Biomarkers Prev 10(5):483-488
43. Nissen SE, Wolski K (2007) Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes. N Engl J Med 356(24):2457-2471
44. Psaty BM, Furberg CD (2007) Rosiglitazone and cardiovascular risk. N Engl J Med 356(24):2522-2524
45. Ridker PM, Danielson E, Fonseca FAH, Genest J, Gotto AM Jr et al (2008) Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med 359(21):2195-2207
46. Platz EA (2007) Epidemiologic musing on statin drugs in the prevention of advanced prostate cancer. Cancer Epidemiology Biomarkers Prev 16(11):2175-2180
47. Li CI, Malone KE, Weiss NS, Daling JR (2001) Tamoxifen therapy for primary breast cancer and risk of contralateral breast cancer. J Natl Cancer Inst 93(13):1008-1113